Similar articles

• Risks of virus transmission associated with animal sera or substitutes and methods of control.

  Eloit M. Eloit M. Dev Biol Stand. 1999;99:9-16. Dev Biol Stand. 1999. PMID: 10404870 Review. No abstract available.
• [Prevention of transfusion-associated viral infection].

  Kojima K, Togashi T. Kojima K, et al. Rinsho Byori. 2003 Feb;Suppl 124:121-6. Rinsho Byori. 2003. PMID: 12710042 Review. Japanese. No abstract available.
• Residual risks of blood transfusion in Rhode Island.

  Sweeney JD, Kurtis J, Starakiewicz J. Sweeney JD, et al. Med Health R I. 2005 Jul;88(7):224-5, 228-31. Med Health R I. 2005. PMID: 16184827 No abstract available.
• [Transfusion of blood and products derived from blood].

  Wautier JL. Wautier JL. Rev Prat. 1999 Feb 15;49(4):409-13. Rev Prat. 1999. PMID: 10319693 Review. French. No abstract available.
• Transfusion safety: Where are we today?

  Luban NL. Luban NL. Ann N Y Acad Sci. 2005;1054:325-41. doi: 10.1196/annals.1345.040. Ann N Y Acad Sci. 2005. PMID: 16339681 Review.